
Organic Process Research and Development p. 387 - 398 (2017)
Update date:2022-09-26
Topics:
Linghu, Xin
Wong, Nicholas
Iding, Hans
Jost, Vera
Zhang, Haiming
Koenig, Stefan G.
Sowell, C. Gregory
Gosselin, Francis
The process development of a synthetic route to manufacture ERK inhibitor GDC-0994 on multikilogram scale is reported herein. The API was prepared as the corresponding benzenesulfonate salt in 7 steps and 41% overall yield. The synthetic route features a biocatalytic asymmetric ketone reduction, a regioselective pyridone SN2 reaction, and a safe and scalable tungstate-catalyzed sulfide oxidation. The end-game process involves a telescoped SNAr/desilylation/benzenesulfonate salt formation sequence. Finally, the development of the API crystallization allowed purging of process-related impurities, obtaining >99.5A% HPLC and >99% ee of the target molecule.
Chemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
Contact:+86-0512-88957371
Address:shanghai
ClickChem Technology Co., Limited
Contact:+86-0310-6519966/0531-52893837
Address:No.750 Shunhua Road, High-Tech Zone, Jinan city, Shandong China
Rizhao Lanxing Chemical Indusrial Co.,Ltd
Contact:86-633-2616708
Address:NO.15 West road Shenglan, Lanshan district, Rizhao City
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Doi:10.1002/adsc.201300419
(2013)Doi:10.1016/j.cplett.2013.08.029
(2013)Doi:10.1002/chem.201300817
(2013)Doi:10.1021/jacs.0c07381
(2020)Doi:10.1021/ja00978a026
(1967)Doi:10.1016/0040-4039(93)89012-F
(1993)